Par Drugs And Chemicals Share: Bull Case vs Bear Case for 2026
- September 17, 2026
- Posted by: Kunal Singla
- Category: Market
Par Drugs And Chemicals Key Stats (17 Sep 2026)
| Sector | Pharmaceutical Bulk Drugs and Intermediates Manufacturing |
| Current Market Price | Rs 130.89 |
| 52 Week High / Low | Rs 180.00 / Rs 78.05 |
| Market Cap (Rs Cr) | 157 |
| P/E Ratio (Industry P/E) | 10.80 (50.28) |
| Return on Equity | 11.71% |
| Debt to Equity | 0.00 |
| EPS (TTM) | Rs 11.78 |
| Dividend Yield | 0.00% |
| Book Value | Rs 91.01 |
| 14 Day RSI | 62.67 |
Quick Answer
The Par Drugs And Chemicals bull case rests on sharp single session rally, while the bear case points to neutral to positive technical setup. At Rs 130.89, the stock sits between its 52 week low of Rs 78.05 and high of Rs 180.00, and both sides of the argument deserve a look before deciding. This article lays out the fundamentals and technical signals so you can weigh the Par Drugs And Chemicals bull case against the risks yourself.
Par Drugs And Chemicals operates in the pharmaceutical bulk drugs and intermediates manufacturing space, and its shares currently trade at Rs 130.89, placing the stock within a 52 week range of Rs 78.05 to Rs 180.00. For anyone building or reviewing a position, the Par Drugs And Chemicals bull case and the bear case both come down to the same underlying numbers read in different lights, and this piece walks through both sides using the company’s latest valuation, profitability, and technical readings.
Rather than pushing you toward one conclusion, this Par Drugs And Chemicals bull case analysis sets out what the bulls see in Par Drugs And Chemicals shares and what the bears are watching, so you can match the picture against your own risk appetite and investment horizon. Understanding the Par Drugs And Chemicals bull case thoroughly, alongside its counterpart, is essential before making any investment decision.
Click Here – Get Free Investment Predictions
Par Drugs And Chemicals Bull Case: Why Par Drugs And Chemicals Could Move Higher
Building the Par Drugs And Chemicals bull case means looking closely at the metrics investors watch most: valuation, profitability, leverage, and price momentum. Here is what supports the Par Drugs And Chemicals bull case for Par Drugs And Chemicals shares right now.
Sharp Single Session Rally: Par Drugs And Chemicals surged nearly 2.9 percent in the latest session, reflecting a burst of investor interest in the pharmaceutical bulk drugs business.
Extraordinarily Deep Discount to Industry Valuation: The stock trades at just 10.80 times earnings against a pharmaceutical industry average of 50.28, one of the widest valuation gaps in this entire batch.
Strong Return on Equity: A return on equity of 11.71 percent reflects efficient capital use in the bulk drugs and intermediates business.
Debt Free Balance Sheet: A debt to equity ratio of 0.00 gives the company complete financial flexibility.
Taken together, these points form the core of the Par Drugs And Chemicals bull case for Par Drugs And Chemicals, though as with any thesis, they should be weighed against the risks on the other side.
Explore the Univest Stock Screener
The Bear Case: Risks Facing Par Drugs And Chemicals
No Par Drugs And Chemicals bull case is complete without an honest look at what could go wrong. The following factors form the bear case for Par Drugs And Chemicals shares.
Neutral to Positive Technical Setup: With the RSI near 62.67, the stock shows a relatively constructive near term trend, though it has already run up meaningfully.
Trading at a Meaningful Premium to Book Value: With a book value of Rs 91.01 per share against a market price of Rs 130.89, the stock trades at a meaningful premium to its accounting net worth.
No Current Dividend: A 0 percent dividend yield means the stock currently offers no income cushion for shareholders.
Extraordinarily Sharp Decline From 52 Week High: The stock trades at roughly 73 percent of its 52 week high of Rs 180.00, reflecting a significant de-rating over the past year.
Download the Univest iOS App or the Univest Android App to track this stock on the go.
Conclusion
The Par Drugs And Chemicals bull case and the bear case for Par Drugs And Chemicals both draw on the same set of numbers, valuation, return on equity, leverage, and price momentum, interpreted from opposite directions. At Rs 130.89, Par Drugs And Chemicals shares sit in a 52 week range of Rs 78.05 to Rs 180.00, and where the stock goes from here will likely depend on which side of the Par Drugs And Chemicals bull case versus bear case debate dominates investor sentiment. As with any stock, independent research and a clear view of your own risk tolerance should guide any final decision, and revisiting the Par Drugs And Chemicals bull case periodically as new data emerges is a sound practice.
Disclaimer: This article is for informational purposes only and should not be construed as investment advice. Univest Research Analyst services are provided under SEBI Registration No. INH000013776. Stock prices, financial ratios, and technical indicators mentioned above are as of 17 Sep 2026 and are subject to change; please verify all data independently before making any investment decision. Past performance is not indicative of future results. Investments in securities are subject to market risk.
Frequently Asked Questions
What is the Par Drugs And Chemicals bull case for the stock?
Ans. The Par Drugs And Chemicals bull case for Par Drugs And Chemicals centers on sharp single session rally, among other factors covered above, though investors should weigh this alongside the risks discussed in the bear case section.
What is the bear case for Par Drugs And Chemicals shares?
Ans. The primary risk highlighted in the bear case is neutral to positive technical setup, and investors should factor this in before making a decision.
What is the current share price of Par Drugs And Chemicals?
Ans. Par Drugs And Chemicals shares currently trade at Rs 130.89, within a 52 week range of Rs 78.05 to Rs 180.00.
What is the P/E ratio of Par Drugs And Chemicals?
Ans. Par Drugs And Chemicals trades at a P/E ratio of 10.80, compared with a broader industry average of around 50.28.
What is the return on equity for Par Drugs And Chemicals?
Ans. Par Drugs And Chemicals reported a return on equity of 11.71 percent.
Is Par Drugs And Chemicals a debt heavy company?
Ans. Par Drugs And Chemicals carries a debt to equity ratio of 0.00, which investors can compare against sector peers to judge balance sheet risk.
What is the 52 week high and low for Par Drugs And Chemicals?
Ans. Par Drugs And Chemicals has a 52 week high of Rs 180.00 and a 52 week low of Rs 78.05.
Should I rely only on this article before investing in Par Drugs And Chemicals?
Ans. No. This Par Drugs And Chemicals bull case article presents both the Par Drugs And Chemicals bull case and the bear case using publicly available fundamentals and technical data as of 17 Sep 2026, but you should verify all figures independently and consider consulting a registered investment adviser before making any investment decision.
